Natroba topical suspension approved for head lice treatment
The FDA has approved Natroba (spinosad, from ParaPRO) topical suspension 0.9% for the treatment of head lice infestations in patients ≥4 years old.
The FDA has approved Natroba (spinosad, from ParaPRO) topical suspension 0.9% for the treatment of head lice infestations in patients ≥4 years old.
Topaz Pharmaceuticals announced the completion of two Phase 3 clinical trials that studied the use of ivermectin topical cream as a potential treatment for head lice.